My favorite kind of ads are the ones that throw in some archeology and a secret historical treasure… I guess I’m just a dime-store novel kind of guy at heart. And this week we’ve got just that from Marc Lichtenfeld, who’s peddling his Oxford Income Letter ($49, renews at $79/yr) with headlines about a secret […]
Articles
Turn down the football game and bring out the pies, it’s that time again! Stock Gumshoe is mostly closed down for the holiday week, but we do have to continue our annual tradition of calling out our “Turkey of the Year” … so take a pause from arguing with your family and join us, won’t […]
The latest pitch from Marc Lichtenfeld begins with a walking tour of Palm Beach, which is just cruel to those of us enduring mud season in New England, but, more importantly, it also comes with a good ol’ fake deadline of midnight tonight… so I guess I better cover this one quick! Fortunes await! The […]
Higher-cost trading service that appears to speculate on “ignition events” using options, mostly betting on companies that are predicted to initiate a dividend in the near future.
This teaser solution was originally published in a Friday File for the Irregulars on November 30. The same ad is still circulating and several new folks have asked about it, so I’m releasing it for all to read today. What follows has not been updated since the end of November, and the ad is also […]
I don’t have any big updates on the Real Money Portfolio this week, or on my big-picture thinking (still holding a lot more cash than usual, still being mindful of stop loss triggers for momentum/growth stocks, still hoping some of my favorites will reach prices that inspire a buy soon, since we’re right in the […]
Have you been watching what’s going on with the trendy pot stocks lately? Holy crap. This reminds me now of 1999 more than it reminds me of the cryptocurrency bubble of this past winter — these larger marijuana companies, like many of the dot com companies (and unlike most cryptos, of course), are real businesses […]
The beginning of the latest ad from Marc Lichtenfeld’s Lightning Trend Trader is good and juicy, at the very least… how could you not open up the ad and pay attention? “The KILLER Hiding in Your Medicine Cabinet “These Common Drugs Take a Life Every 12 Minutes (Who’s at Risk?) “Here’s the NEW Breakthrough and […]
Fear Of Missing Out is such a big deal that it gets its own acronym in my book (FOMO — and a clever FOMO-fueling website here), and it drives investors to take huge chances just so they don’t have to worry about missing a chance at stupendous gains. That’s what many newsletter ads use to […]
Welcome back from vacation, me! There’s no question what ad should be covered first as I brush the sand off my feet and turn up the heat here at Gumshoe HQ… it’s the pitch from Marc Lichtenfeld for his Lightning Trend Trader over at Oxford Club, and the “special report” he’s dangling as bait. That […]
This stock certainly has Gumshoe Nation in a bit of a lather… though it’s also one that many of you already know about, and the solution to this teaser is not super-secret (it has been posted in recent discussions here at Stock Gumshoe a few times). Marc Lichtenfeld puts out a newsletter advisory called Lightning […]
This article originally appeared on July 22, 2015, and the bulk of it has not been updated or revised since. The meat of the ad is essentially the same, and if Lichtenfeld really “bet his paycheck” on this stock (which was and is Alnylam) on July 22 he’s so far lost about 65% of that […]
Nobody likes a monopoly… except investors, of course. We love monopolies, as long as we can own shares. There’s almost nothing better than a lack of competition, because that gives pricing power and better margins and a nice steady stream of profits. And if you can own a monopoly company that also pays out a […]
Marc Lichtenfeld has an ad running this week that talks about a business that could be the “most profitable I’ve ever seen” — and one that’s so entrenched in our country that he says the equivalent of 10% of US GDP relies on this one company. So who is it? Well, he gets into some […]
Marc Lichtenfeld’s trading service that tries to “ride the lightning” by uncovering catalysts that will send stocks soaring. Often covers biotech stocks.
This article originally ran on January 12… the teaser pitch was still being circulated heavily last week, and the stock released earnings on February 3 that disappointed investors, bringing shares down about 15% (it was teased as a “$7 biotech,” and briefly $8, before then). The original Jan. 14 “special event” catalyst teased by Lichtenfeld, […]
[This article was originally published on May 29, 2014, we’re bumping it back to the top because a lot of readers have asked about it this week. The article below has not been updated or revised since first publication on 5/29/14] Gumshoe readers have been asking about the “President’s Private Stock Market” for quite a […]
Another Monday morning, another “next wave of the internet” teaser. This teaser comes in from the Oxford Income Letter, edited by Marc Lichtenfeld over at the Oxford Club, and it’s a bit of a departure from the crazy small cap names he has more often touted of late (usually for his MicroCap Tech Trader newsletter). […]
Publishes educational material for investors.
I’ve got a handful of updates for you, including one on a stock that I bought yesterday and a few other notes about recent quarterly reports from stocks I follow, but first … a teaser to solve … When I wrote about Marc Lichtenfeld’s pitch for “Spread Trusts” yesterday, I promised to also try to […]
Monthly newsletter focusing on income investments.
Every biotech-related teaser ad promises that you can make life-changing profits while also curing the world of a dread disease, of course — that’s why we love ’em. But this one’s a little bit different — they are teasing a biotech company that is trying to develop new drugs, but according to the pitch this […]
Marc Lichtenfeld, who we’ve covered a number of times in this space, focuses largely on biotech investments — he’s teased a number of them for a variety of different newsletters that he has helmed or contributed to, but it looks like he’s now launching a new letter from the Oxford Club called FirstLine Investor Alert. […]
Biotech-focused newsletter from Lichtenfeld, who previously edited the similar-sounding Access Group letters for White Cap Research.
Last year Marc Lichtenfeld started promoting a new service in which he promised to identify “active shares” that effectively let you choose your own price — and although he had plenty of hype in that letter that sounded utterly foolish, as usual, he was at least partly right about the stock’s performance (he got the […]
Weekly newsletter with recommendations of stocks that are or may be targeted by activist investors. No longer publishing.
Today’s delightful tidbit of teasermania comes in from Marc Lichtenfeld, who tends to focus on biotech and health care stocks. He’s been around for a while, and is now drumming up members for the Oxford Club instead of one of his own biotech-focused letters, and pitching some ideas that sound like they’re a little larger […]
That headline came across my desk on a tease from Marc Lichtenfeld, who I’ve certainly covered in the past — but this time, he’s teasing a brand new advisory called The Activist Trader that apparently hasn’t even started publishing yet. So in case you’re tempted to become one of his guinea pigs, let’s look and […]
Ah, a good old promise of biotech riches — I haven’t dug into one of these in ages, nothing beats the wild biotech stocks that can see their share price climb 200% (or fall 90%) on a single bit of news. This tease is from Marc Lichtenfeld, whose biotech stuff we’ve looked at several times […]
Now this is a nice promise: “If This Stock Doesn’t Double Between Now and June 25, I’ll Write You an Apology – Along With a Check for $1,250” Of course, one assumes that this only applies to the folks who pony up that same $1,250 for a subscription to the Access Research Group newsletter (and, […]
That sounds pretty good, right? It’s everyone’s dream, a rich great-uncle that you never knew, and years later you find out that you were left a fortune in his will, and he’s been dead for years and a banker’s knocking at the door trying to give you a bag full of Krugerrands. Ah, those are […]
This ad has been crashing in on Gumshoe beach in massive waves over the last week, so I thought it might be time to take a gander. It’s for the Xcelerated Profits report at Mt. Vernon Research — the last time I saw a similar ad it was from Karim Rahemtulla for this same report, […]
This is an ad that probably many of you have already seen, from Marc Lichtenfeld for his Access Group newsletter. And yes, like so many ads do, they’re guaranteeing that you’ll double your money if you invest in this idea. Which gives me a chance for a quick little digression before we dig into the […]
Healthcare-focused newsletter, recommended stocks primarily of emerging device and biotech companies. Was helmed by Marc Lichtenfeld, who moved on to other publications, but stopped publishing after a short while — Lightning Trend Trader, a current publication of Lichtenfeld’s with The Oxford Club, sometimes covers biotech stocks.
Today’s teaser ad is from Marc Lichtenfeld and his Access Group — they specialize in part on medical and biotech stocks, and the first two ads we’ve looked at them are in that area. The first one was for the “$4 Cancer Detection Device that could go to $196,” which you might remember turned out […]
This one comes in from what looks to be a new newsletter service called “The Access Group” that will run you $2,750 a year. Phew. This is a service that they claim will enable individual investors to get access to the kind of research hedge fund companies used to pay these analysts $30,000 a year […]
Comments
I don't know what 5G companies they are talking about.... I wasn't willing to pay the $49 dollars to find out LOL.I wo...
This is the second time I thought that about him too and it appears as though you're right. If you look at the put optio...
I got the Ray Blanco email and was curious so did some digging and came up with the same company. They were one of the...
Does anyone know if One Web (aka World Vu) has actually filed an S-1 report as Ray Blanco claims? Also How and where can...
Ray Blanco is talking about an announcement soon (May 2019) that will change forever the field of medicine and provide t...
Hi Lynda, I was about to join for Ray Blanco advise but after seeing all complaints I am not subscribing, can you send ...
Ray Blanco id full of $h!+...
Dear Travis I was going to join Matt McCall's program, I just canceled with Ray Blanco. After I did that I seen A report...
I would forget about that with Agora, I had sent 4 emails to Ray Blanco never got one reply. I just canceled today with ...
Hi Travis what about the Halo-Fi company one web and what Ray Blanco is touting about how to get in on the IPO or pre IP...
Ray Blanco is telling me that the marijuana stocks for the first round are going to be (CARA), ( XXII), (TRTC) and a bon...
My experience with Ray Blanco is that many if not most of his Marijuana recommendations come weeks to months AFTER the ...
what is this company ray blanco is talking about in the andes mountain and asking 1995 for the advice of the stock to bu...
Ray Blanco added VFFIF (Village Farms) to his Penny Pot Portfolio last Thursday and it popped 25% in 2 days....
Are they just changing the dates on the announcement? In researching this, seems he first said it was going to be announ...
Anyone know what penny stock Ray Blanco is talking about? The Apple Inc. of weed?...
Is this the same pitch Ray Blanco made today on pro.sevenfiguresolutions.com about a $6.38 trillion "cure for all cures"...
Is this the Ray Blanco pot pitch? It hasn't changed much over the years, though I haven't looked at a recent iteration ...
Ray Blanco was touting a new altheimers stock and this was a bonus report! would also like to know the .25 cent stock he...
Well, in 2015 Ray Blanco with Agora Financial was promoting a cure for Alzheimers with a drug called Anavex (AXVL). This...
Does anyone own Sangamo Therapeutics. (SGMO) I should call myself the "Greenhorn" because I know virtually nothing about...
That's a term popularized by Ray Blanco's ad copywriters -- some satellite stocks have done incredibly this year, mostly...
I too have for too long look to these publications for some help only to find out they are only created as a prelude as ...
Recently subscribed to his Biotech Insider etc,looking to create a late pension,I'm 72.I'm quite frankly pissed off watc...
Agree, as soon as I see the names Ray Blanco, James Altucher, Tim Sykes, anywhere on the message, I delete it....
Not bad, the biotech index (IBB) is only up 40-50% since March of 2014 (that was a volatile month, it depends on what da...
Joined the service when it was launched. I spend a lot of time with the FDA trader recommendations. But it has payed ...
Ray Blanco is one of many techno-thief who should be put in jail for his many false and misleading statements and scams....
I don't attention to Ray Blanco. I don't trust him at all....
I wish the stock SGMO to change Medicine Forever stock had performed as you predicted. What do you predict for the futu...
We covered that ad this morning, in case anyone missed it: https://www.stockgumshoe.com/reviews/fda-trader/blancos-no-mo...
Does anyone know the Company or stock that he is talking about? I don't want to spend $1500 to find out from Ray Blanco...
I too am interested in what Ray Blanco, FDA Trader, is talking about. A big announcement on Wed., Sept. 5 about how a D...
I don't bother opening anything with "Ray Blanco" on it, just hit delete....
Anyone know the four pot stocks Ray Blanco is promoting...
Ray Blanco and a few others are also pitching this $1 marijuana stock that you must be in before the end of August that ...
Does anyone know what public company Ray Blanco is talking about when he says they are giving out "covert" shares of a s...
So what is the $0.11 stock let us all know so we can beat Ray Blanco...
I'm trying to assess the opportunity for an investment in Promis Neurosciences. They are a pre-clinical stage biotech co...
Thank you for bringing us back down to earth on Ray Blanco article on Halo fi. It was much appreciated!!...
Same story received in mail today or yesterday promoting the same Technology Profits Confidential newsletter. This time ...
Yes, SES is one of the companies doing something similar to what OneWeb is trying to do, and they already have a constel...
Travis it is from Agora and Ray Blanco; Breakthrough Technology Alert I believe. The link: https://pro.agorafinancial.c...
I think the problem that Ray Blanco fails to mention is that the satellite signal can be disrupted by rain and snow just...
Being new to stock trading, what a time to start!; I really appreciate your website. I'm so burnt out on the teaser ads ...
Looks like Ray Blanco is giving it away today. 49 bucks for a year does not seem like highway robbery to me. I am going ...
Is the Agora you belong to the same as the Technology Profits Confidential by this Ray Blanco? I Googled "Technology Pr...
It seems that the price of marijuana stocks rides much more on the recommendations of investment advisers than on their...
Of all the advisors at Agora, Steve Sjuggerud and Ray Blanco have been the best for my investments. You can talk Ray dow...
I think the author of this article is politely trying to say that Ray Blanco is hyping NewWeb with his October 1 / Decem...
Is that the "Halo-Fi" one Ray Blanco has been touting? If so, I covered that here: https://www.stockgumshoe.com/reviews...
OOPS The NOV 8 is also Ray Blanco. I guess he found out he was wrong about Oct. OOPS sorry bout that...
No concern. Ray Blanco is from a different Agora run publisher than the new link for the same thing. Talk about playi...
I see a few things that don't quite add up here. Firstly, Ray Blanco is pushing it, therefore I suggest that this is so...
BTW, this was not Ray Blanco, but Greg Guenthner....
Haven't seen a specific stock teased by them (that's Ray Blanco at Agora Financial, right?), but he has tried a few pot ...
I am a new newbie looking to join Ray Blanco group, from reading your blogs not sure, you people have some very good inf...
I wouldn't buy any Ray Blanco BS. He says he has the only penny stock index. There is already a North American Marijuana...
Honor roll post for Ben! I've read Ray Blanco some, and he doesn't exactly strike me as someone to follow in the biotech...
$ATNM long - Ray Blanco does not know his but from hole in ground as massive appreciation shall come from 'the other can...
#ATNM - - Today from Ray Blanco of Technology Confidential Report: Actinium Pharmaceuticals (NYSE: ATNM) has been the...
Travis guessed $CARA (no position) was one of the stocks teased by Ray Blanco back on November 3rd to profit from mariju...
I do look at penny stocks, but haven't looked at marijuana stocks recently. If it's the one I've seen from Ray Blanco, ...
WATT? No shocking announcement by Apple that iPhone7 will be using Energous's wireless charging technology? I am shocked...
Travis; a new talent slumbering in you just has been discovered! I read the patent and question the utility of the appro...
I don't know about this particular case but I signed up for technology profits and one thing I could say for sure Ray Bl...
Whoops, meant to say Ray Blanco, NOT Dalia!...
Agora’s 100B MJ tease: http://research.agorafinancial.com/research/html/ftr_pennyshockwave_0616/? Travis, what equi...
Travis, Is it possible that President Jimmy Carter was given t-cells to rid him of his cancer. When I read of his cur...
FDA Clears the Way for a New Atomic Age $ATNM: This is from Ray Blanco, editor of Technology Profits Confidential. He ...
$ATNM: This from Ray Blanco of Technology Profits Confidential. We have great news from Actinium Pharmaceuticals (NY...
Dr. KSS & JimT: Anacor (ANAC) - this came up in an earlier thread that both you and JimT commented on. Your comments ar...
ray blanco is teasing a scientific process called cellular oil. I want to find out what gumshoe thinks about it....
Actually Ray Blanco writes the cheap Technology Profits Confidential. I think he's Patrick Cox researcher but I wouldn't...